Global Point-of-care Testing (POCT) Market Trends, Key Regions, Revenue, Future Scenario and Top Players like F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Johnson & Johnson, Alere

Global Point-of-Care Testing (POCT) Market is projected to reach 38.2 billion by 2024
Major factors driving the market for Point-Of-Care Testing Market, such as increasing geriatric population, increase in infectious diseases (hepatitis, HIV infection, influenza, respiratory infections and others), technological advancements, introduction of home-based point of care devices, and rapid economic development in the emerging economies. These factors such as increased awareness among the population, ease of use, rapid test, right dosage to the right place

Point-of-care Testing (POCT) Market report provides in-depth statistics and analysis available on the market status of the POCT Manufacturers and is a valuable method of obtaining guidance and direction for companies and business enterprise insider considering the point of care testing market Industry.

New report of Global Point-of-care Testing (POCT) Market Trends and Forecast to 2024 Overview By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others),By Prescription Mode (Prescription Based Testing & Over-The-Counter Testing),By Distribution Channel (Direct Tenders & Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World)

Ask for Free Sample Report Visit @http://databridgemarketresearch.com/request-a-sample/?dbmr=point-care-testing-poct-market

Data Bridge Market Research new Insight’s on “Global Point-of-Care Testing (POCT) Market is projected to reach 38.2 billion by 2024, from USD 18.5 billion in 2016 growing at a CAGR of 9.5% during the forecast period of 2017 to 2024”.

Avail 10% Discount on Direct PurchaseGlobal Point-of-Care Testing Market” Or kindly send the email at sopan.gedam@databridgemarketresearch.com

Recent Developments

The demand for point-of-care testing (POCT) is growing due to the value-shift in healthcare and increasing technological advancements. Also, the rising prevalence of lifestyle and infectious diseases, early detection of diseases, and management of multiple chronic conditions is fueling the growth of the market. Some of the other factors contributing to the growth of the market are Private investments and venture funding, new product development and government support, increasing adoption of POC devices, and miniaturization of devices. On the other hand, factors such as pricing pressure, low reimbursement, and XX are restraining the growth of the market.

Factors such as emerging market, growing patient pool, rising number of partnerships and joint ventures, and rising initiatives by the market players will contribute to the growth of the market in future. Also, the current focus of the companies on the development of devices for diagnosis and treatment of cancer, stroke, and cardiac patients will drive the market in future. To compete with other POCT companies in the future, POCT companies will need to employ a different set of digital strategies and connectivity solutions.

The global point-of-care market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. “F. Hoffmann-La Roche Ltd” dominated the point-of-care market accounting for a highest market share in 2016, followed by “Siemens AG” and “Abbott”.

Any specific requirements are you looking for? Ask to your Industry Experts@: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=point-care-testing-poct-market

Some Key Players:

Other players in this market include Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, OPTI Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, Inc, bioMérieux SA, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedicaamong others holds 53.1% of the global injectable drug delivery market in 2016.

F. HOFFMANN-LA ROCHE LTD:

Historical Background – Roche was established in 1896

Nature of Business: F. Hoffmann-La Roche Ltd., is one of the largest biotech company with 17 biopharmaceuticals on the market. The company is operating in more than 100 countries around the globe. Some of the subsidiaries are Genetech, Roche Diagnostics, Chugai Pharmaceutical Co., Ventana Medical Systems, InterMune, Inc., Syntex, Anadys Pharmaceuticals, Roche Applied Science, Bioveris, Roche products, Inc., Roche pharma AG, Pt Roche Indonesia, Bina Technologies, Inc., nv Roche sa, Roche SAS, Roche Glycart AG, Roche Co., Ltd.

Main focus: Since the establishment in 1896, the company’s main focus is on oncology, immunology, ophthalmology, infectious diseases and neuroscience.

Main Business Areas: Pharmaceuticals and Diagnostics.

Recent Developments:

  1. In August 2016,Roche Diagnostics Ltd., received FDA approval for cobas Influenza A/B & RSV test for the cobasLiat System that differentiates flu and Respiratory Syncytial Virus (RSV) in 20 minutes
  2. In May 2015, Roche Diagnostics Ltd., received FDA CLIA Waiver for the cobasLiat PCR System and Strep A assay to test Strep A in throat swab specimen.
  3. In December 2014, Roche Diagnostics Ltd, received FDA approval for LightMix Ebola Zaire rRT-PCR Test at the time of emergency to treat Ebola Zaire virus infection.

Any specific requirements are you looking for? Ask to your Industry Experts: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=point-care-testing-poct-market

Global Point-of-Care Testing (POCT) Market: Geographic Segmentation

The global point-of-care testing market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. For instance, in June 2015, Roche launched its Cardiac point-of-care (POC) troponin test for the cobas h 232 system which is available for countries which accept the CE Mark. This product has improved accuracy at low concentrations and it will help in diagnosis of heart attack patients with high mortality risk. The report includes company share data for different geographies including Global, North America, Europe and APAC.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Global Point-of-Care Testing (POCT) Market Categories: Segmentation

The global point-of-care testing market is segmented on the basis of product, prescription mode, distribution channel, end user and geography.

On the basis of product the market is segmented into 13 major segments which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.

Cardiometabolic Monitoring Kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing. Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections), respiratory infections testing kits, others. Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.

Based on prescription mode, the global point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing. The OTC testing is projected to witness higher growth during the forecast period.

On the basis of distribution channel, the market is segmented into direct tenders and retail. In 2017, the direct tender market is expected to dominate the market.

On the basis of end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory. Hospital segment is further categorized into emergency department critical-care unit, general ward, and others (intensive care unit, neo-natal). Also, clinic is segmented into physicians’ clinic and diagnostic clinic. In 2017, the hospitals segment is expected to dominate the global point-of-care testing market with more than 42.5% market share.

Read More About Detail Table of Content, Figures and Tables @: http://databridgemarketresearch.com/toc/?dbmr=point-care-testing-poct-market

TABLE OF CONTENTS GLOBAL POINT-OF-CARE TESTING MARKET

1. INTRODUCTION

 

1.1. OBJECTIVES OF THE STUDY

1.2. MARKET DEFINITION

1.3. OVERVIEW OF GLOBAL POINT-OF-CARE TESTING MARKET

1.4. CURRENCY AND PRICING

1.5. LIMITATION

1.6. MARKETS COVERED

 

2. MARKET SEGMENTATION

 

2.1. MARKETS COVERED

2.2. GEOGRAPHIC SCOPE

2.3. YEARS CONSIDERED FOR THE STUDY

2.4. CURRENCY AND PRICING

2.5. RESEARCH METHODOLOGY

2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7. SECONDARY SOURC

2.8. ASSUMPTIONS

 

3. MARKET OVERVIEW

 

3.1. DRIVERS

 

3.1.1. GROWING GERIATRIC POPULATION

3.1.2. ADVANCEMENT IN TECHNOLOGY

3.1.3. DECENTRALIZED LABORATORY TESTING

3.1.4. INCREASED INCIDENCE OF CHRONIC DISEASES

3.1.5. LABORATORY STAFF SHORTAGES

 

3.2. RESTRAINTS

 

3.2.1. UNFAVOURABLE REIMBURSEMENT SCENARIO

3.2.2. ECONOMIC COST

 

3.3. OPPORTUNITIES

 

3.3.1. EMERGING MICROFLUIDIC LAB-ON-A-CHIP TECHNOLOGY

3.3.2. EMERGING MARKETS

3.3.3. UNMET MEDICAL NEEDS

 

3.4. CHALLENGES

 

3.4.1. LACK OF ACCURACY AND EFFICIENCY

3.4.2. DATA MANAGEMENT AND LACK OF CONNECTIVITY

3.4.3. TESTING PERFORMED BY NON-LABORATORY PERSONNEL AND LACK OF AWARENESS AMONG THE USERS

 

4. EXECUTIVE SUMMARY

 

5. PREMIUM INSIGHTS

 

6. GLOBAL POINT-OF-CARE TESTING MARKET: REGULATORY SCENARIO

 

6.1. OVERVIEW:

 

6.1.1. REGULATORY PROCEDURE:

 

7. GLOBAL POINT-OF-CARE TESTING MARKET: REIMBURSEMENT SCENARIO

 

7.1. OVERVIEW:

 

8. GLOBAL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE

 

8.1. OVERVIEW

 

8.2. CARDIOMETABOLIC MONITORING KITS

 

8.2.1. CARDIAC MARKERS

8.2.2. BLOOD GAS ELECTROLYTE TESTING KITS

8.2.3. HBA1C TESTING KITS

8.2.4. LIPID TESTING KITS

 

8.3. INFECTIOUS DISEASE TESTING KITS

 

8.3.1. INFLUENZA TESTING KITS

8.3.2. HIV TESTING KITS

8.3.3. HEPATITIS TESTING KITS

8.3.4. STD TESTING KITS

8.3.5. TROPICAL DISEASESTESTING KITS

8.3.6. HEALTHCARE ASSOCIATED TESTING KITS

8.3.7. RESPIRATORY INFECTIONS TESTING KITS

 

8.4. CHOLESTEROL TESTING KITS

 

8.4.1. PROTHROMBIN TIME TESTING KITS

8.4.2. ACTIVATED CLOTTING TIME TESTING KITS

 

8.5. BLOOD GLUCOSE TESTING KITS

 

8.6. PREGNANCY AND FERTILITY TESTING KITS

 

8.7. TUMOR CANCER MARKERS

 

8.8. URINALYSIS TESTING KITS

 

8.9. HEMATOLOGY TESTING KITS

 

8.10. DRUGS OF ABUSE TESTING KITS

 

8.11. FECAL OCCULT TESTING KITS

 

8.12. RAPID COAGULATION TESTING KITS

 

9. GLOBAL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL

 

9.1. OVERVIEW

 

9.1.1. DIRECT TENDER

9.1.2. RETAIL PHARMACY

 

10. GLOBAL POINT-OF-CARE TESTING MARKET, BY END USER

 

10.1. OVERVIEW

10.2. GLOBAL POCT MARKET: HOSPITALS

10.3. GLOBAL POCT MARKET: CLINICS

10.4. GLOBAL POCT MARKET: AMBULATORY CARE

10.5. GLOBAL POCT MARKET: HOME HEALTHCARE

10.6. GLOBAL POCT MARKET: RESEARCH LABORATORIES

 

11. GLOBAL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE

 

11.1. OVERVIEW

11.2. GLOBAL POCT MARKET: PRESCRIPTION BASED TESTING KITS

11.3. GLOBAL POCT MARKET: OVER THE COUNTER BASED TESTING KITS

 

12. GLOBAL POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY

 

12.1. OVERVIEW

 

12.2. NORTH AMERICA POINT-OF-CARE TESTING MARKET

 

12.2.1. U.S.POINT-OF-CARE TESTING MARKET

12.2.2. CANADA POINT-OF-CARE TESTING MARKET

12.2.3. MEXICO POINT-OF-CARE TESTING MARKET

 

12.3. EUROPE POINT-OF-CARE TESTING MARKET

 

12.3.1. GERMANY POINT-OF-CARE TESTING MARKET

12.3.2. FRANCE POINT-OF-CARE TESTING MARKET

12.3.3. U.K. POINT-OF-CARE TESTING MARKET

12.3.4. ITALY POINT-OF-CARE TESTING MARKET

12.3.5. SPAIN POINT-OF-CARE TESTING MARKET

12.3.6. RUSSIA POINT-OF-CARE TESTING MARKET

12.3.7. TURKEY POINT-OF-CARE TESTING MARKET

12.3.8. BELGIUM POINT-OF-CARE TESTING MARKET

12.3.9. NETHERLANDS POINT-OF-CARE TESTING MARKET

12.3.10. SWITZERLAND POINT-OF-CARE TESTING MARKET

12.3.11. REST OF EUROPE POINT-OF-CARE TESTING MARKET

 

12.4. APAC POINT-OF-CARE TESTING MARKET

 

12.4.1. JAPAN POINT-OF-CARE TESTING MARKET

12.4.2. CHINA POINT-OF-CARE TESTING MARKET

12.4.3. SOUTH KOREA POINT-OF-CARE TESTING MARKET

12.4.4. INDIA POINT-OF-CARE TESTING MARKET

12.4.5. AUSTRALIA POINT-OF-CARE TESTING MARKET

12.4.6. SINGAPORE POINT-OF-CARE TESTING MARKET

12.4.7. THAILAND POINT-OF-CARE TESTING MARKET

12.4.8. MALAYSIA POINT-OF-CARE TESTING MARKET

12.4.9. INDONESIA POINT-OF-CARE TESTING MARKET

12.4.10. PHILIPPINES POINT-OF-CARE TESTING MARKET

12.4.11. REST OF APAC POINT-OF-CARE TESTING MARKET

 

12.5. MEA POINT-OF-CARE TESTING MARKET

 

12.5.1. SOUTH AFRICA POINT-OF-CARE TESTING MARKET

12.5.2. SAUDI ARABIA POINT-OF-CARE TESTING MARKET

12.5.3. UAE POINT-OF-CARE TESTING MARKET

12.5.4. REST OF MEA POINT-OF-CARE TESTING MARKET

 

12.6. SOUTH AMERICA POINT-OF-CARE TESTING MARKET

 

12.6.1. BRAZIL POINT-OF-CARE TESTING MARKET

 

13. GLOBAL POINT-OF-CARE TESTING MARKET : COMPANY LANDSCAPE

 

13.1. COMPANY SHARE ANALYSIS: GLOBAL

13.2. COMPANY SHARE ANALYSIS: NORTH AMERICA

13.3. COMPANY SHARE ANALYSIS: EUROPE

13.4. COMPANY SHARE ANALYSIS: APAC

 

14. COMPANY PROFILES

 

14.1. JOHNSON AND JOHNSON SERVICES, INC.

 

14.1.1. COMPANY OVERVIEW

14.1.2. REVENUE ANALYSIS

14.1.3. PRODUCT PORTFOLIO

14.1.4. RECENT DEVELOPMENTS

 

14.2. BECTON, DICKINSON AND COMPANY

 

14.2.1. COMPANY OVERVIEW

14.2.2. REVENUE ANALYSIS

14.2.3. PRODUCT PORTFOLIO

14.2.4. RECENT DEVELOPMENTS

 

14.3. MEDTRONIC

 

14.3.1. COMPANY OVERVIEW

14.3.2. REVENUE ANALYSIS

14.3.3. PRODUCT PORTFOLIO

14.3.4. RECENT DEVELOPMENTS

 

14.4. F. HOFFMANN-LA ROCHE LTD

 

14.4.1. COMPANY OVERVIEW

14.4.2. REVENUE ANALYSIS

14.4.3. PRODUCT PORTFOLIO

14.4.4. RECENT DEVELOPMENTS

 

14.5. SIEMENS AG

 

14.5.1. COMPANY OVERVIEW

14.5.2. REVENUE ANALYSIS

14.5.3. PRODUCT PORTFOLIO

14.5.4. RECENT DEVELOPMENTS

 

14.6. ABBOTT

 

14.6.1. COMPANY OVERVIEW

14.6.2. REVENUE ANALYSIS

14.6.3. PRODUCT PORTFOLIO

14.6.4. PRODUCT PIPELINE

14.6.5. RECENT DEVELOPMENTS

 

14.7. DANAHER

 

14.7.1. COMPANY OVERVIEW

14.7.2. REVENUE ANALYSIS

14.7.3. PRODUCT PORTFOLIO

14.7.4. RECENT DEVELOPMENTS

 

14.8. WERFENLIFE

 

14.8.1. COMPANY OVERVIEW

14.8.2. REVENUE ANALYSIS

14.8.3. PRODUCT PORTFOLIO

14.8.4. RECENT DEVELOPMENTS

 

14.9. HENRY SCHEIN, INC.

 

14.9.1. COMPANY OVERVIEW

14.9.2. REVENUE ANALYSIS

14.9.3. PRODUCT PORTFOLIO

14.9.4. RECENT DEVELOPMENTS

 

14.10. OPTI MEDICAL (SUBSIDIARY OF IDEXX LABORATORIES, INC)

 

14.10.1. COMPANY OVERVIEW

14.10.2. REVENUE ANALYSIS

14.10.3. PRODUCT PORTFOLIO

14.10.4. RECENT DEVELOPMENTS

 

14.11. SIENCO, INC.

 

14.11.1. COMPANY OVERVIEW

14.11.2. REVENUE ANALYSIS

14.11.3. PRODUCT PORTFOLIO

14.11.4. RECENT DEVELOPMENTS

 

14.12. ACON LABORATORIES, INC.

 

14.12.1. COMPANY OVERVIEW

14.12.2. REVENUE ANALYSIS

14.12.3. PRODUCT PORTFOLIO

14.12.4. RECENT DEVELOPMENTS

 

14.13. ATIVA MEDICAL CORPORATION

 

14.13.1. COMPANY OVERVIEW

14.13.2. REVENUE ANALYSIS

14.13.3. PRODUCT PORTFOLIO

14.13.4. RECENT DEVELOPMENTS

 

14.14. ABAXIS

 

14.14.1. COMPANY OVERVIEW

14.14.2. REVENUE ANALYSIS

14.14.3. PRODUCT PORTFOLIO

14.14.4. RECENT DEVELOPMENTS

 

14.15. ARKRAY, INC

 

14.15.1. COMPANY OVERVIEW

14.15.2. REVENUE ANALYSIS

14.15.3. PRODUCT PORTFOLIO

14.15.4. RECENT DEVELOPMENTS

 

14.16. AERSCHER DIAGNOSTICS, LLC

 

14.16.1. COMPANY OVERVIEW

14.16.2. REVENUE ANALYSIS

14.16.3. PRODUCT PORTFOLIO

14.16.4. RECENT DEVELOPMENTS

 

14.17. ARTRON LABORATORIES, INC.

 

14.17.1. COMPANY OVERVIEW

14.17.2. REVENUE ANALYSIS

14.17.3. PRODUCT PORTFOLIO

14.17.4. RECENT DEVELOPMENTS

 

14.18. BIOMERIEUX SA

 

14.18.1. COMPANY OVERVIEW

14.18.2. REVENUE ANALYSIS

14.18.3. PRODUCT PORTFOLIO

14.18.4. RECENT DEVELOPMENTS

 

14.19. ENTOPSIS

 

14.19.1. COMPANY OVERVIEW

14.19.2. REVENUE ANALYSIS

14.19.3. PRODUCT PORTFOLIO

14.19.4. RECENT DEVELOPMENTS

 

14.20. LIFESIGN, LLC.

 

14.20.1. COMPANY OVERVIEW

14.20.2. REVENUE ANALYSIS

14.20.3. PRODUCT PORTFOLIO

14.20.4. RECENT DEVELOPMENTS

 

15. RELATED REPORTS

Read more about the Global Point-of-Care Testing (POCT) Market Report Visit @ http://databridgemarketresearch.com/reports/point-care-testing-poct-market/

Other Market Insights:

The Global Molecular Spectroscopy Market, latest insights by Data Bridge Market Research states that the market is growing at CAGR of 5.0% in the forecast period 2017 to 2024, expected to reach USD 6.712 Billion by 2024.

Report Access: http://databridgemarketresearch.com/reports/global-molecular-spectroscopy-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://databridgemarketresearch.com/reports/point-care-testing-poct-market/